secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aquestive Therapeutics, Inc. (AQST)
CIK:        0001398733
Form:       8-K
Filed at:   2023-01-03T23:59:59+00:00
Accession:  0001628280-23-000057
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Aquestive receives Nasdaq deficiency notice for bid price below $1.00
---------------------------------------------------------------------

- Nasdaq notified Aquestive on Dec 30, 2022 that its common stock bid price was below $1.00 for 30 consecutive days.
- Company has 180 days, until June 28, 2023, to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant by deadline, Aquestive may transfer to Nasdaq Capital Market for an additional 180-day cure period.
- Company may consider a reverse stock split to address the bid price deficiency.
- Failure to regain compliance could result in delisting of AQST common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1398733/000162828023000057/0001628280-23-000057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1398733/000162828023000057/aqst-20221230.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-000057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer